Love Your Liver is a national awareness month devoted to liver health awareness and giving people the key steps needed to keep their liver healthy.
We spoke to Ochre Bio, a liver medicines company, to find out what they're up to in this space.
Welcome to the first CEO blog of 2022, one I’m delighted not to have penned from an overpriced hotel room in San Francisco – my normal place of work this time of year. A new year normally means a fresh start, but it seems the year will again be dominated by how governments and global economies will respond to the COVID-19 pandemic.
BioNTech SE and Crescendo Biologics Ltd today announced that they have entered a multi-target discovery collaboration to develop novel immunotherapies for the treatment of patients with cancer and other diseases.
Stablepharma officials claim their patented StablevaX™ technology can thermally stabilize and deliver a wide range of vaccines without the requirement for refrigeration. They say their stabilized vaccine solution could eliminate the need for the cold chain and enable stockpiling anywhere in the world. StablevaX is designed to enhance the performance of existing and new vaccines, according to the company.
CRACK IT Challenges is a challenge-led competition that funds collaborations between industry, academics and SMEs to solve business and scientific Challenges which will deliver scientific, commercial and animal welfare benefits, either by improving business processes or developing a commercial product. We are seeking new challenges from industry and academic institutions to run in our 2022 competition.
Atheras Analytics, a UK-based company in the satellite telecommunications sector, has secured funding from the UK Innovation & Science Seed Fund (UKI2S). The funding will allow Atheras to extend the capabilities of its SaaS-based software tools to cover a wider range of satellites and orbits.
Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform, KerusCloud, to establish a more efficient data-driven approach to study design and protocol development within Renovion’s clinical development programs.
Closed Loop Medicine has closed £13 million of new investment from a range of top UK and European venture capital investors. The money has been raised to finance its personalised drug plus digital therapy (DTx) combination products which are being developed to improve outcomes for patients and clinicians through precision dosing.